- cafead Jan 09, 2023 at 10:42: AM
via An Alzheimer’s drug, a hemophilia gene therapy and two breast cancer drugs are among the top decisions on the agency’s docket through the end of March.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
5 FDA decisions to watch in the first quarter
- Thread starter cafead
- Start date
<
Similar threads